Selegiline

CHEMBL972 Phase 4 ได้รับการอนุมัติ Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

187.3 g/mol

LogP

2.8

Phase

4

Used in the early stages of Parkinson's disease, this medication slows the breakdown of dopamine in the brain by inhibiting the MAO-B enzyme. It may also have mild neuroprotective properties and is sometimes prescribed alongside levodopa to help extend its effectiveness.

น้ำหนักโมเลกุล

187.2800 g/mol

LogP

2.80

TPSA

3.20 Å²

Lipinski RO5

ผ่าน

ด้านการรักษา

Alzheimer's Disease Parkinson's Disease Schizophrenia Major Depressive Disorder Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure

Embed this structure

SMILES

C#CCN(C)[C@H](C)Cc1ccccc1

InChI

InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1

Molecular Formula

C13H17N

HBD / HBA

- / 1

พันธะที่หมุนได้

4

อะตอมหนัก

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Used in the early stages of Parkinson's disease, this medication slows the breakdown of dopamine in the brain by inhibiting the MAO-B enzyme. It may also have mild neuroprotective properties and is sometimes prescribed alongside levodopa to help extend its effectiveness.

Yes, Selegiline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL972. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 26757. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

กำลังมองหาข้อมูลที่เข้าใจง่ายสำหรับผู้ป่วยอยู่ใช่ไหม?

Selegiline บน PillFYI

โครงสร้าง

ข้อมูลด่วน

สูตร: C13H17N
คำพ้องความหมาย: 3

ลิงก์ภายนอก

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.